Position in GERN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$697
-$1,427 QoQ
Shares Held
545
-63.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#245
of 258 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Optiver Holding B.V. holds $14,292,933 across 180 Biotechnology names. GERN ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
76,368 | $10,176,799 | |
| 2 | TECH |
BIO-TECHNE Corp
|
8,493 | $600,030 | |
| 3 | NBTX |
Nanobiotix S.A.
|
13,631 | $513,888 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
652 | $323,867 | |
| 5 | BNTX |
BioNTech SE
|
2,150 | $200,057 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
22,559 | $197,504 | |
| 7 | ARGX |
Argenx SE
|
174 | $161,431 | |
| 8 | VNDA |
Vanda Pharmaceuticals Inc.
|
18,089 | $110,704 |
All Filings in GERN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $697 | 545 | Shares | Defined | 2026-08-12 | |
| 2025-06-30 | $2,124 | 1,507 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $15,954 | 4,507 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,488 | 3,852 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,714 | 5,829 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||